FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40260311000001101: Tepmetko 225mg tablets (Merck Serono Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2087501000001111 Tepmetko 225mg tablets (Merck Serono Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2087521000001116 Tepmetko 225mg tablets (Merck Serono Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tepmetko 225mg tablets (Merck Serono Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Is a Tepotinib 225mg tablets true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction restricted availability true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Is a Tepmetko true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has specific active ingredient Tepotinib hydrochloride false Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tepotinib false Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has specific active ingredient Tepotinib hydrochloride true Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tepotinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tepmetko 225mg tablets (Merck Serono Ltd) 60 tablet Has AMP True Tepmetko 225mg tablets (Merck Serono Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start